- Home
- AXSM vs ZK Comparison
AXSM vs ZK Comparison
Compare AXSM & ZK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- ZK
- Stock Information
- Founded
- AXSM 2012
- ZK 2017
- Country
- AXSM United States
- ZK China
- Employees
- AXSM N/A
- ZK N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- ZK
- Sector
- AXSM Health Care
- ZK
- Exchange
- AXSM Nasdaq
- ZK NYSE
- Market Cap
- AXSM 4.7B
- ZK N/A
- IPO Year
- AXSM 2015
- ZK 2024
- Fundamental
- Price
- AXSM $90.73
- ZK $27.55
- Analyst Decision
- AXSM Strong Buy
- ZK Strong Buy
- Analyst Count
- AXSM 14
- ZK 3
- Target Price
- AXSM $125.93
- ZK $30.80
- AVG Volume (30 Days)
- AXSM 499.7K
- ZK 777.4K
- Earning Date
- AXSM 02-18-2025
- ZK 02-14-2025
- Dividend Yield
- AXSM N/A
- ZK N/A
- EPS Growth
- AXSM N/A
- ZK N/A
- EPS
- AXSM N/A
- ZK N/A
- Revenue
- AXSM $338,457,000.00
- ZK $9,907,011,177.00
- Revenue This Year
- AXSM $44.89
- ZK N/A
- Revenue Next Year
- AXSM $68.41
- ZK $41.41
- P/E Ratio
- AXSM N/A
- ZK N/A
- Revenue Growth
- AXSM 51.47
- ZK 42.56
- 52 Week Low
- AXSM $64.11
- ZK $13.00
- 52 Week High
- AXSM $105.00
- ZK $32.24
- Technical
- Relative Strength Index (RSI)
- AXSM 42.16
- ZK N/A
- Support Level
- AXSM $89.09
- ZK N/A
- Resistance Level
- AXSM $94.64
- ZK N/A
- Average True Range (ATR)
- AXSM 3.64
- ZK 0.00
- MACD
- AXSM -1.14
- ZK 0.00
- Stochastic Oscillator
- AXSM 20.64
- ZK 0.00
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.